
Dermapharm Holding SE
- Jurisdiction
Germany - LEI
5299009F0KNZINQQQK37 - ISIN
DE000A2GS5D8 (DMP.DE )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
8
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. Read full profile
Stock price
Fundamentals
- Net revenue
€1.18B - Gross margin
65.7% - EBIT
€218.27M - EBIT margin
18.5% - Net income
€107.20M - Net margin
9.1%
Statement period: - (published )
Dividends
- Last dividend amount
-
€0.90 - Ex date
-
- Payment date
-
Analyst ratings
3 analysts rated this company in the past 90 days. The average target price is €39.67, this is a change of +22.6% compared to the current price.